CompaniesChordia Therapeutics
Chordia Therapeutics logo

Chordia Therapeutics

active
Fujisawa, Japan
Founded 2017
Website
About

Oncology Treatments

Areas of Focus

Categories

Small Molecule PharmaceuticalJapan
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

225

By Phase

PHASE1/PHASE2: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
NCT05732103
Hover over trial bars to see details

Recent Trials

NCT05732103Lead Sponsor
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
PHASE1/PHASE2Recruiting
225 participants
Started: Apr 25, 2023 · Completed: Feb 28, 2029
Locations (1)
Headquarters
Fujisawa, Japan
Map

Loading map...